DLTR
52
8
HRB
40
3
BMY
40
-5
JPM
59
6
DE
49
3
TROW
37
8
EXPE
83
8
EMC
30
-26
HES
49
2
DRI
74
5
LOW
42
14
GOOGL
62
6
AMGN
42
14
MHK
25
5
L
54
5
BXP
39
5
SO
48
6
GRMN
53
3
FAST
41
7
FCX
44
4
DLTR
52
8
HRB
40
3
BMY
40
-5
JPM
59
6
DE
49
3
TROW
37
8
EXPE
83
8
EMC
30
-26
HES
49
2
DRI
74
5
LOW
42
14
GOOGL
62
6
AMGN
42
14
MHK
25
5
L
54
5
BXP
39
5
SO
48
6
GRMN
53
3
FAST
41
7
FCX
44
4
Financhill
Back

Apellis Pharmaceuticals Stock Predictions

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Buy
53

APLS
Apellis Pharmaceuticals

Last Price:
$33.23
Seasonality Move:
14.66%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Apellis Pharmaceuticals Stock Forecast

  • Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 21.1% based on the past 7 years of stock performance.
  • Apellis Pharmaceuticals has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
  • Is Apellis Pharmaceuticals Stock Undervalued?
    The current Apellis Pharmaceuticals [APLS] share price is $33.18. The Score for APLS is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Apellis Pharmaceuticals Stock Go Up Next Year?

  • Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 21.1% based on the past 7 years of stock performance.

Apellis Pharmaceuticals Stock Rating

Buy
53
Apellis Pharmaceuticals (APLS) is a Buy

Is Apellis Pharmaceuticals overpriced?

  • Apellis Pharmaceuticals has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%

Apellis Pharmaceuticals Stock Price History

Is APLS stock going to rise?

  • The current trend is moderately bullish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
apellis.com

52-Week Data

52-Week High:
73.80
52-Week Low:
24.34

Prediction Charts

Market Cap:
4.1B
Price in USD:
33.18
Volume:
3.6M
Beta:
0.88

Technical Analysis

SMA50:
30.14
SMA100:
32.72
SMA200:
39.25
52-Wk Change:
-39.64%

Stock Predictions

  • Is Apellis Pharmaceuticals stock public?
    Yes, Apellis Pharmaceuticals is a publicly traded company.
  • What is the Apellis Pharmaceuticals stock quote today?
    The Apellis Pharmaceuticals stock price is 33.18 USD today.
  • How to buy Apellis Pharmaceuticals stock online?
    You can buy Apellis Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 35.01 34.63 35.38 33.82
Dec-4 34.62 34.13 34.76 33.76
Dec-5 33.97 33.45 34.23 32.67
Dec-6 33.74 33.49 34.37 33.16
Dec-9 33.80 35.02 35.72 33.35
Dec-10 35.22 34.64 35.35 34.21
Dec-11 34.92 34.00 34.97 33.97
Dec-12 33.53 32.74 34.10 32.30
Dec-13 32.60 33.19 33.50 31.76
Dec-16 33.19 33.66 34.98 32.71
Dec-17 32.98 34.53 34.83 32.74
Dec-18 34.53 34.02 35.71 33.73
Dec-19 34.13 33.14 34.25 32.88
Dec-20 33.16 33.18 34.27 32.89

Apellis Pharmaceuticals Earnings

Apellis Pharmaceuticals Earnings Report: Per Share Apellis Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Apellis Pharmaceuticals Forecast Revenue Growth

Apellis Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Apellis Pharmaceuticals and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.77 per share, and an increase next year of $0.82 per share.

* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.